NCT03364426

Brief Summary

Child stunting remains an important global health issue, with 157 million children under five years of age estimated to be stunted in 2014. Until recently, stunting was thought to occur in the first 1000 days of life (between conception and 2 years of life), and was thought to be largely irreversible thereafter. However, emerging research suggests that children can transition between stunted and non stunted status up to 15 years of age, with studies also suggesting potential implications in terms of cognitive status. Despite this, there is little research on stunting and its potential determinants among children of older ages, with most current studies confined to those under five. This study aims to assess the prevalence of stunting and examine potential sociodemographic determinants of stunting (including individual, maternal and household level indices) among older children (aged 6-19 years) in a Malaysian population.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,759

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2012

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 12, 2012

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 23, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 23, 2014

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

November 30, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 6, 2017

Completed
Last Updated

December 8, 2017

Status Verified

December 1, 2017

Enrollment Period

2.4 years

First QC Date

November 30, 2017

Last Update Submit

December 6, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Child stunting

    Stunting was expressed using the Centers for Disease Control and Prevention 2000, and the World Health Organization 2007 references.

    This was a one-time measurement, taken during a survey.

Secondary Outcomes (1)

  • Child height-for-age

    This was a one-time measurement, taken during a survey (as above).

Interventions

No intervention - this is was an observational, cross-sectional study to identify potential risk factors associated with stunting

Eligibility Criteria

Age6 Years - 19 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

This study is based on existing observational data collected by the the South East Asia Community Observatory (SEACO), a health and demographic surveillance system (HDSS) covering approximately 45 000 individuals in Segamat, Malaysia. The HDSS regularly (annually) enumerates all consenting households and individuals within its catchment area, and has also conducted a health survey to date during which basic sociodemographic, lifestyle-related and anthropometric data were collected from individuals aged 6 years and above. Further information on the SEACO HDSS can be found at: https://academic.oup.com/ije/article/46/5/1370/4037470.This study uses cross-sectional data on children aged 6-19 years, collected between 2012-2014.

You may qualify if:

  • Age \>= 6 years and \<= 19 years
  • Whether or not the potential participant has information on all exposure and outcome variables of interest.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Partap U, Young EH, Allotey P, Soyiri IN, Jahan N, Komahan K, Devarajan N, Sandhu MS, Reidpath DD. HDSS Profile: The South East Asia Community Observatory Health and Demographic Surveillance System (SEACO HDSS). Int J Epidemiol. 2017 Oct 1;46(5):1370-1371g. doi: 10.1093/ije/dyx113. No abstract available.

    PMID: 29024948BACKGROUND

Related Links

MeSH Terms

Conditions

Growth Disorders

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Daniel D Reidpath, PhD

    Monash University Malaysia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Reader in Global Health and Population Sciences, Division of Computational Medicine, Department of Medicine

Study Record Dates

First Submitted

November 30, 2017

First Posted

December 6, 2017

Study Start

April 12, 2012

Primary Completion

September 23, 2014

Study Completion

September 23, 2014

Last Updated

December 8, 2017

Record last verified: 2017-12